There is no standard clinical guidance for cycling the stack because human trial data is minimal
Plasma was separated and stored at 80 C within one hour of collection
Any significant deviation from the initial appearancesuch as darkening, fading, cloudiness, or particle formationshould prompt immediate contact with the compounding pharmacy before administration
Contraindications and Precautions Consider avoiding BPC-157 if you have: History of cancer or active malignancy Pregnancy or breastfeeding (no safety data) Competitive athletic status (WADA prohibits peptides) Known sensitivity to peptide products Severe cardiovascular disease (limited data) Blood pressure monitoring may be prudent given the nitric oxide modulation effects
A 2025 systematic review by Vasireddi and colleagues in HSS Journal screened 544 published papers and identified 36 meeting inclusion criteria 35 preclinical studies and only one human study: an uncontrolled, unblinded, retrospective case series of 12 patients receiving intra-articular BPC-157 for chronic knee pain, in which 7 of 12 (58%) reported self-described relief lasting more than 6 months, with no dose, effect size, or systematically collected adverse events published
In general, excessive levels of vitamins and minerals can be hard on the organs and should be avoided
